Edgar Jost
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 52
- Acute Myeloid Leukemia Research 34
- Chronic Myeloid Leukemia Treatments 12
- Hematopoietic Stem Cell Transplantation 10
-
- Epigenetics and DNA Methylation 17
- Co-authors
- Stefan Wilop (29 shared papers)R. Osieka (19 shared papers)Oliver Galm (26 shared papers)James G. Herman (8 shared papers)Martina Crysandt (18 shared papers)Stefan Barth (10 shared papers)Edgar Dahl (4 shared papers)Tim H. Brümmendorf (16 shared papers)
- Journals
- Blood (10 papers)Leukemia (6 papers)Annals of Hematology (5 papers)Clinical Epigenetics (4 papers)British Journal of Haematology (4 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Edgar Jost
98 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 90
- Hematology 496
- Genetics 267
- Immunology 290
- Oncology 346
- Molecular Biology 862
Countries citing papers authored by Edgar Jost
This map shows the geographic impact of Edgar Jost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Jost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Jost more than expected).
Fields of papers citing papers by Edgar Jost
This network shows the impact of papers produced by Edgar Jost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Jost. The network helps show where Edgar Jost may publish in the future.
Co-authors
The 25 scholars most cited alongside Edgar Jost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 136 | |
| 2 | 2004 | 107 | |
| 3 | 2011 | 86 | |
| 4 | 2008 | 77 | |
| 5 | 2008 | 75 | |
| 6 | 2005 | 71 | |
| 7 | 2007 | 63 | |
| 8 | 2012 | 60 | |
| 9 | 2008 | 54 | |
| 10 | Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells. | 2003 | 46 |
| 11 | 2013 | 42 | |
| 12 | 2008 | 39 | |
| 13 | 2009 | 39 | |
| 14 | 2008 | 37 | |
| 15 | 2011 | 33 | |
| 16 | 2008 | 33 | |
| 17 | 2010 | 32 | |
| 18 | 2009 | 32 | |
| 19 | 2007 | 32 | |
| 20 | 2012 | 30 |
About Edgar Jost
Edgar Jost is a scholar working on Hematology, Molecular Biology, Genetics, Immunology and Oncology, having authored 102 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (34 papers), Epigenetics and DNA Methylation (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers), Chronic Myeloid Leukemia Treatments (12 papers), Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Toxin Mechanisms and Immunotoxins (7 papers). The work is most often cited by research in Hematology (496 citations), Genetics (267 citations), Immunology (290 citations), Oncology (346 citations) and Molecular Biology (862 citations). Edgar Jost has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Stefan Wilop, R. Osieka, Oliver Galm, James G. Herman, Martina Crysandt, Stefan Barth, Edgar Dahl, Tim H. Brümmendorf, Gerald Gehbauer and Tim H. Brümmendorf. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Clinical Epigenetics and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.